Validation of a blood-based autoantibody test to assess lung cancer risk in 4–30 mm pulmonary nodules: a retrospective pooled analysis of four cohort studies

Q: What does this research mean for the field?

The blood-based autoantibody test (AAT) identifies subsets of patients with 4–30 mm pulmonary nodules whose malignancy risk justifies expedited evaluation, independent of nodule size. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Trevor J. Pitcher; Kathryn J. Long; Michael N. Kammer; S Schuldheisz; Bharat Bajantri; Tammy Gleeson; Dragos Zanchi; SANDEEP BANSAL; Luke Yuhico; Laura J. Peek; James R. Jett; V. Nair; Gerard A. Silvestri

doi:10.1080/14796694.2026.2626339

February 17, 2026Future Oncology

Validation of a blood-based autoantibody test to assess lung cancer risk in 4–30 mm pulmonary nodules: a retrospective pooled analysis of four cohort studies

View at Publisher

Ask AI

Bookmark

Share

Key Points

The research aims to validate a blood-based autoantibody test to assess lung cancer risk in patients with pulmonary nodules.
Conducted a retrospective pooled analysis of four cohort studies
Evaluated autoantibody test performance based on nodule size and risk
Calculated specificity of the test in identifying malignancy risk
The autoantibody test showed high specificity in identifying patients at risk for malignancy
The test helped identify risk independently of nodule size
Subsets of patients identified may benefit from expedited evaluation for lung cancer

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Retrospective analysis validates a blood test to assess lung cancer risk in patients with pulmonary nodules, suggesting quicker evaluations for at-risk subsets.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pitcher et al. (2026) studied this question.

synapsesocial.com/papers/6997fa26ad1d9b11b345321e https://doi.org/10.1080/14796694.2026.2626339

View at Publisher

Ask AI

Bookmark

Share

Validation of a blood-based autoantibody test to assess lung cancer risk in 4–30 mm pulmonary nodules: a retrospective pooled analysis of four cohort studies

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Validation of a blood-based autoantibody test to assess lung cancer risk in 4–30 mm pulmonary nodules: a retrospective pooled analysis of four cohort studies

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading